Xu Li1,2, Wenqi Wang3, Junjie Chen4
1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Mass spectrometry-based proteomics is revolutionizing disease research by identifying protein malfunctions. This technology enhances understanding of disease mechanisms, aiding in prevention, diagnosis, and treatment.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: